November 3rd, 2011 by PJSkerrett in Expert Interviews
No Comments »
Dr. Jerry Avorn
Americans spend more than $300 billion a year on prescription drugs. How we use these drugs, and how effective they are, have become important subjects for public health researchers. A leader in this area is Dr. Jerry Avorn, chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital in Boston and professor of medicine at Harvard Medical School. Avorn is the author of numerous articles and the book Powerful Medicines.
For an article in the Harvard Health Letter, editor Peter Wehrwein spoke with Avorn about generic drugs, the pharmaceutical industry, the high cost of cancer drugs, and more. Here’s an excerpt from their conversation; you can read the complete interview at www.health.harvard.edu. Read more »
*This blog post was originally published at Harvard Health Blog*
October 27th, 2011 by Richard Cooper, M.D. in Opinion
No Comments »
(Note: After a five month absence from posting comments, I offer this observation, with more to come. There’s much to do.)
The message resonating from the Wall Street protesters is that income inequality doesn’t work. And among the developed nations, theUS is the most unequal. This distinction does not come without cost. The greatest, of course, is the social cost borne by those who are poor. But what the protesters may not fully realize is that another is the high costs of health care. This is because the costs of caring for the poor are much greater. And together with the rising numbers of poor patients, they are crushing the health care system.
This notion may seem shocking, since it is generally believed that low-income patients receive less health care. After all, many have little or no health insurance, and most have poor access to primary care. Isn’t it the wealthy whose access is best and who use the most? The answer is Read more »
*This blog post was originally published at PHYSICIANS and HEALTH CARE REFORM Commentaries and Controversies*
October 24th, 2011 by John Di Saia, M.D. in News
No Comments »
The British HM Revenue and Customs is planning to impose a tax on cosmetic surgeries by slapping VAT on any artificial enhancements and procedures. According to the new guidelines by the department responsible for collecting UK’s taxes, doctors performing more invasive procedures will have to register for VAT and pass the charge on to their patients. The guidelines suggest that patients having such cosmetic procedures will have to pay the tax unless they can persuade the doctor that the operation is being carried out for “therapeutic” reasons. Although the move is being considered to help plug the deficit in Britain’s public finances, but Fazel Fatah, president of the British Association of Aesthetic Plastic Surgeons (BAAPS), said that this could harm many patients.
Source: dnaindia.com/lifestyle/report_boob-tax-to-increase-cost-of-cosmetic-surgery-by-20-per-cent_1599777
The government in the UK seeks to hasten the movement of cosmetic surgery business out of the country it seems. That will likely be the effect of the planned extension of the VAT tax to cosmetic surgery. It is already less expensive for British citizens to leave the country for their cosmetic surgery. The care in most cases is not equivalent. The reason to consider it just got 20% more persuasive however. That is a huge tax!
Here in the US, Read more »
*This blog post was originally published at Truth in Cosmetic Surgery*
October 20th, 2011 by PreparedPatient in Health Policy, True Stories
1 Comment »
A couple weeks ago I walked the streets of Lincoln, Nebraska, talking to men and women about whether they thought Washington was listening to their economic concerns. Jeff Melichar manages his family’s Phillips 66 gas station on the city’s main street, and one of his big financial problems happens to be health insurance. The more we talked, the more I realized what a jam he could be in down the road because of a loophole in the health reform law, which has received almost no press coverage or public discussion: If you have health insurance from your employer, you may have to keep it whether or not it’s adequate or affordable. Buying less expensive or better coverage from one of the state “exchanges” or shopping services will be off limits. So despite all that talk about consumer choice, for many like the Melichars, there may be no choice.
Melichar’s wife is eligible for health insurance from the optical company where she works. But the family waited until this fall to enroll when the firm offered coverage they finally could afford. Their premium is Read more »
*This blog post was originally published at Prepared Patient Forum: What It Takes Blog*
October 19th, 2011 by KennyLinMD in Health Policy, Opinion
No Comments »
The past few months have offered encouraging signs that physicians and physician organizations are belatedly recognizing the need to take an active role in controlling health care costs by emphasizing “high-value” care and minimizing the use of low-value interventions with high costs and few clinical benefits. On the heels of a best practice guideline issued by his organization, American College of Physicians Executive VP Steven Weinberger, MD recently called for making cost-consciousness and stewardship of health resources a required general competency for graduate medical education.
In light of a recently published estimate that the top 5 overused clinical activities in primary care specialties led to $6.7 billion in wasted health spending in 2009, Dr. Weinberger’s call comes none to soon. Below is an excerpt from my post on this topic from April 13, 2010. Read more »
*This blog post was originally published at Common Sense Family Doctor*
